SCHEMBL22182117

SCHEMBL22182117

Cc1cc(-c2ccc(NCCCN3C(=O)c4cccc5cccc(c45)C3=O)cc2)ccc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 3/20 0.50
▸ HEXA P06865 6/20 0.49
▸ HEXB P07686 6/20 0.49
▸ MAPT P10636 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ OGA O60502 1/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ POLB P06746 2/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ AHR P35869 1/20 0.46
▸ RAD52 P43351 1/20 0.46
▸ RCE1 Q9Y256 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22181861 0.90 SIRT1 (0.53) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22182084 0.87 SIRT1 (0.47) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22181885 0.87 SIRT1 (0.49) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22182085 0.86 SIRT1 (0.47) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22181894 0.86 SIRT1 (0.53) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22181892 0.86 SIRT1 (0.51) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22181854 0.86 SIRT1 (0.57) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22181889 0.85 LPAR2 (0.52) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22181986 0.85 SIRT1 (0.47) SIRT1HEXAHEXBMAPTALDH1A1
SCHEMBL22182115 0.84 SIRT1 (0.49) SIRT1HEXAHEXBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020139291-A1 NAPHTHALIMIDE DERIVATIVES AS ANTI-PARASITIC AGENTS FOR THE TREATMENT OF LEISHMANIASIS AS WELL AS VIRAL, BACTERIAL AND NEOPLASTIC DISEASES ISTANBUL MEDIPOL UNIVERSITESI (TR) 2020-07-02 — — WO disclosed
Send feedback